La boîte à outils de l’Institut Jérôme Lejeune

PATHOLOGIES DERMATOLOGIQUES  Dermatologie et trisomie 21 - introduction PLAN DU CHAPITRE 1- Dermatologie et trisomie 21 – introduction 2- Dermatologie courante et trisomie 21 – partie 1 3- Dermatologie courante et trisomie 21 – partie 2 4- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 1 5- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 2 6- Pathologies dermatologiques de survenue anecdotique dans la trisomie 21 (bientôt disponible) Le docteur Hervé Walti, pédiatre à l’Institut Jérôme Lejeune, nous introduit, dans cette vidéo et dans la fiche technique qui l’accompagne, la dermatologie dans la trisomie 21. Découvrez l’intégralité du chapitre « Pathologies dermatologiques » en cliquant sur "Plan du chapitre" à droite de l'image en haut de l'article. https://youtu.be/cNdQM-Qiphw Télécharger la fiche récapitulative Découvrez ci-dessous la présentation associée à cette vidéo. Voir les références Aase JM. The physical examination : Hands and feet – Minor variants ; in Aase JM (ed) : Diagnostic Dysmorphology. New York, Plenum Medical Book Co, 1990, pp 236–237.Asen D. Secrets in fingerprints : clinical ambitions and uncertainty in dermatoglyphics. CMAJ. 2018 May 14;190(19):E597-E599.Blok J, Jonkman M, Horváth B. The possible association of hidradenitis suppurativa and Down syndrome : is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link? Br J Dermatol. 2014 Jun;170(6):1375-7.Bull MJ, Trotter T, Santoro SL, Christensen C, Grout RW; COUNCIL ON GENETICS; Burke LW, Berry SA, Geleske TA, Holm I, Hopkin RJ, Introne WJ, Lyons MJ, Monteil DC, Scheuerle A, Stoler JM, Vergano SA, Chen E, Hamid R, Downs SM, Grout RW, Cunniff C, Parisi MA, Ralston SJ, Scott JA, Shapira SK, Spire P. Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics. 2022 May 1;149(5):e2022057010.Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397-9.Contaldo M, Lucchese A, Romano A, Della Vella F, Di Stasio D, Serpico R, Petruzzi M. Oral Microbiota Features in Subjects with Down Syndrome and Periodontal Diseases: A Systematic Review. Int J Mol Sci. 2021 Aug 26;22(17):9251.Cummins H. Dermatoglyphic stigmata in mongoloid imbeciles. Anat Rec 1939;73:407-15.Cummins H, Talley C, Platou RV. Palmar dermatoglyphics in mongolism. Pediatrics 1950;5:241-8.Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007 May-Jun;24(3):317-20.Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015 Jul;26(6):385-91.Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996 Nov;50(5):317-20.Fölster-Holst R, Rohrer T, Jung AM. Dermatological aspects of the S2k guidelines on Down syndrome in childhood and adolescence. J Dtsch Dermatol Ges. 2018 Oct;16(10):1289-1295.Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020 Apr 26;38:621-648.Fitzpatrick V, Rivelli A, Chaudhari S, Chicoine L, Jia G, Rzhetsky A, Chicoine B. Prevalence of infectious diseases among 6078 individuals with Down syndrome in the United States. J Patient Cent Res Rev. 2022;9:64-9.Herzog V, Kirfel G, Siemes C, Schmitz A. Biological roles of APP in the epidermis. Eur J Cell Biol. 2004 Dec;83(11-12):613-24.von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol. 1998 Mar;91(3):319-23.Kanbara Y, Takeuchi C, Mochizuki Y, Osako M, Sasaki M, Miyake H. Medical Needs of Adults with Down Syndrome Presenting at a Regional Medical and Rehabilitation Center in Japan. J Nippon Med Sch. 2023 May 30;90(2):210-219.Kato Y, Yamamoto T. Eruptive collagenoma in a juvenile patient with Down syndrome. An Bras Dermatol. 2022 Sep-Oct;97(5):687-688.Määttä T, Määttä J, Tervo-Määttä T, Taanila A, Kaski M, Iivanainen M. Healthcare and guidelines: a population-based survey of recorded medical problems and health surveillance for people with Down syndrome. J Intellect Dev Disabil. 2011 Jun;36(2):118-26.Malle L, Patel RS, Martin-Fernandez M, Stewart OJ, Philippot Q, Buta S, Richardson A, Barcessat V, Taft J, Bastard P, Samuels J, Mircher C, Rebillat AS, Maillebouis L, Vilaire-Meunier M, Tuballes K, Rosenberg BR, Trachtman R, Casanova JL, Notarangelo LD, Gnjatic S, Bush D, Bogunovic D. Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells. Nature. 2023 Mar;615(7951):305-314.Patel D, Li P, Bauer AJ, Castelo-Soccio L. Screening Guidelines for Thyroid Function in Children With Alopecia Areata. JAMA Dermatol. 2017 Dec 1;153(12):1307-1310.Pikora TJ, Bourke J, Bathgate K, Foley KR, Lennox N, Leonard H. Health conditions and their impact among adolescents and young adults with Down syndrome. PLoS One. 2014 May 12;9(5):e96868.PNDS: Trisomie 21, HAS 2020. Téléchargeable sur www.has-sante.frRajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018 Nov;179(5):1033-1048.Reed TE, Borgaonkar DS, Conneally PM, Yu P, Nance WE, Christian JC, et al. Dermatoglyphic nomogram for the diagnosis of Down’s syndrome. J Pediatr 1970;77:1024-32.Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep;37(5):811-816.Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatr Dermatol. 2021 Nov;38 Suppl 2:49-57.Schepis C, Romano C. Cutaneous findings in the mentally retarded. Int J Dermatol. 1996 May;35(5):317-22.Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205(3):234-8.Sokoloff A, Dykman M, Sokoloff G, Vellody K, Holland K, Rork J. If my hidradenitis had a voice, this is what it would say: the perspective of a young woman with Down syndrome and hidradenitis suppurativa. Br J Dermatol. 2023 Jul 17;189(2):221-222Sureshbabu R, Kumari R, Ranugha S, Sathyamoorthy R, Udayashankar C, Oudeacoumar P. Phenotypic and dermatological manifestations in Down Syndrome. Dermatol Online J. 2011 Feb 15;17(2):3.Tazi-Ahnini R, di Giovine FS, McDonagh AJ, Messenger AG, Amadou C, Cox A, Duff GW, Cork MJ. Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet. 2000 Jun;106(6):639-45.Vigarios E, de Bataille C, Boulanger M, Fricain JC, Sibaud V. Variations physiologiques de la langue [Normal variations in lingual soft tissue]. Ann Dermatol Venereol. 2015 Oct;142(10):583-92; quiz 581-2, 593-4. French.Wentworth AB, Hand JL, Davis DM, Tollefson MM. Skin concerns in patients with trisomy 21 (Down syndrome): A Mayo Clinic 22-year retrospective review. Pediatr Dermatol. 2021 Nov;38 Suppl 2:73-78....

PATHOLOGIES DERMATOLOGIQUES  Dermatologie courante et trisomie 21 - partie 1 PLAN DU CHAPITRE 1- Dermatologie et trisomie 21 – introduction 2- Dermatologie courante et trisomie 21 – partie 1 3- Dermatologie courante et trisomie 21 – partie 2 4- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 1 5- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 2 6- Pathologies dermatologiques de survenue anecdotique dans la trisomie 21 (bientôt disponible) Le docteur Hervé Walti, pédiatre à l’Institut Jérôme Lejeune, nous parle, dans cette vidéo et dans la fiche technique qui l’accompagne, de la dermatologie dans la trisomie 21. Découvrez l’intégralité du chapitre « Pathologies dermatologiques » en cliquant sur "Plan du chapitre" à droite de l'image en haut de l'article. https://youtu.be/QkjR3xEAtkk Télécharger la fiche récapitulative Découvrez ci-dessous la présentation associée à cette vidéo. Voir les références Ali SY, Manne V, Manne R, Himani C. Neurofibromatosis, Down's syndrome, and acquired abnormalities. Indian Dermatol Online J. 2016 May-Jun;7(3):198-200.Alter SJ, McDonald MB, Schloemer J, Simon R, Trevino J. Common Child and Adolescent Cutaneous Infestations and Fungal Infections. Curr Probl Pediatr Adolesc Health Care. 2018 Jan;48(1):3-25.Al-Maweri SA, Tarakji B, Al-Sufyani GA, Al-Shamiri HM, Gazal G. Lip and oral lesions in children with Down syndrome. A controlled study. J Clin Exp Dent. 2015 Apr 1;7(2):e284-8.Anderson S. Café au Lait Macules and Associated Genetic Syndromes. J Pediatr Health Care. 2020 Jan-Feb;34(1):71-81.Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P. Positionspapier: Diagnostik und Therapie der Xerosis cutis. J Dtsch Dermatol Ges. 2018 Jul;16 Suppl 4:3-35.Axéll T, Skoglund A. Chronic lip fissures. Prevalence, pathology and treatment. Int J Oral Surg. 1981 Oct;10(5):354-8.Axéll T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy 1976;27:1-103.Bagatin E, Kamamoto CS, Guadanhim LR, Sanudo A, Dias MC, Barraviera IM, Colombo FC. Prevalence of acne vulgaris in patients with Down syndrome. Dermatology. 2010;220(4):333-9.Bagatin E, Timpano DL, Guadanhim LR, Nogueira VM, Terzian LR, Steiner D, Florez M. Acne vulgaris: prevalence and clinical forms in adolescents from São Paulo, Brazil. An Bras Dermatol. 2014 May-Jun;89(3):428-35.Bilgili SG, Akdeniz N, Karadag AS, Akbayram S, Calka O, Ozkol HU. Mucocutaneous disorders in children with down syndrome: case-controlled study. Genet Couns. 2011;22(4):385-92.Blagec T, Glavina A, Špiljak B, Bešlić I, Bulat V, Lugović-Mihić L. Cheilitis: A cross-sectional study-multiple factors involved in the aetiology and clinical features. Oral Dis. 2023 Nov;29(8):3360-3371.Blok J, Jonkman M, Horváth B. The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link? Br J Dermatol. 2014 Jun;170(6):1375-7. doi: 10.1111/bjd.12887.Bonifaz A, Saúl A, Mena C, Valencia A, Paredes V, Fierro L, Araiza J. Dermatophyte onychomycosis in children under 2 years of age: experience of 16 cases. J Eur Acad Dermatol Venereol. 2007 Jan;21(1):115-7.Butterworth T, Leoni EP, Beerman H, Wood MG, Strean LP. Cheilitis of mongolism. J Invest Dermatol. 1960 Dec;35:347-52.Camacho, F.M.; Mazuecos, J.; Ferrándiz, L. Cantalejo, C.; Cabello, Á. Phenotypical and dermatological findings of Down syndrome in Southern Spain. Eur. J. Pediat. Derm. 2014, 24, 7–12.Carlstedt K, Krekmanova L, Dahllöf G, Ericsson B, Braathen G, Modéer T. Oral carriage of Candida species in children and adolescents with Down's syndrome. Int J Paediatr Dent. 1996 Jun;6(2):95-100.Carvalho AA, Ferraz LDA, Martelli DRB, Machado RA, Martelli Júnior H. Craniofacial findings in syndromes associated with cafe-au-lait spots: a literature review. Rev Assoc Med Bras (1992). 2023 Jan 9;69(1):195-202.Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397-9.Cardoso Fernandes LC, de Araújo Oliveira J, Rabello PM, Santiago BM, Diniz de Carvalho MV, Soriano EP. Cheiloscopy in individuals with Down syndrome and their nonsyndromic biological siblings. J Forensic Odontostomatol. 2019 Sep 30;37(2):9-17.Coattrenec Y, Terrani I, Spoer D. La Rev Med Suisse 2018 ; 14 : 746-50.Contaldo M., Santoro R., Romano A., Loffredo F., Di Stasio D., Della Vella F., Scivetti M., Petruzzi M., Serpico R., Lucchese A. Oral Manifestations in Children and Young Adults with Down Syndrome: A Systematic Review of the Literature. Appl. Sci. 2021;11:5408.Cozzani E, Agnoletti AF, Speziari S, Schiavetti I, Zotti M, Persi A, Drago F, Parodi A. Epidemiological study of onychomycosis in older adults with onychodystrophy. Geriatr Gerontol Int. 2016 Apr;16(4):486-91.Dall'Oglio F, Nasca MR, Gerbino C, Micali G. An Overview of the Diagnosis and Management of Seborrheic Dermatitis. Clin Cosmet Investig Dermatol. 2022 Aug 6;15:1537-1548.Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007 May-Jun;24(3):317-20.Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T, Jafferany M, Grabbe S, Goldust M. Acanthosis nigricans: A review. J Cosmet Dermatol. 2020 Aug;19(8):1857-1865.Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015 Jul;26(6):385-91.de Lusignan S, Alexander H, Broderick C, Dennis J, McGovern A, Feeney C, Flohr C. The epidemiology of eczema in children and adults in England: A population-based study using primary care data. Clin Exp Allergy. 2021 Mar;51(3):471-482. doi: 10.1111/cea.13784. Epub 2020 Nov 26. PMID: 33179341; PMCID: PMC7984097.Drivenes JL, Vasilescu IC, Bygum A. Keratosis pilaris. Tidsskr Nor Laegeforen. 2023 Mar 7;143(5). English, Norwegian.Egemen A, Ikizoğlu T, Ergör S, Mete Asar G, Yilmaz O. Frequency and characteristics of mongolian spots among Turkish children in Aegean region. Turk J Pediatr. 2006 Jul-Sep;48(3):232-6.Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996 Nov;50(5):317-20.Finn OA, Grant PW, McCallum DI, Raffle EJ. A singular dermatosis of Mongols. Arch Dermatol. 1978 Oct;114(10):1493-4.Firsowicz M, Boyd M, Jacks SK. Follicular occlusion disorders in Down syndrome patients. Pediatr Dermatol. 2020 Jan;37(1):219-221.Fitzpatrick V, Rivelli A, Chaudhari S, Chicoine L, Jia G, Rzhetsky A, Chicoine B. Prevalence of infectious diseases among 6078 individuals with Down syndrome in the United States.J Patient Cent Res Rev. 2022;9:64-9.Fonseca CT, Amaral DM, Ribeiro MG, Beserra IC, Guimarães MM. Insulin resistance in adolescents with Down syndrome: a cross-sectional study. BMC Endocr Disord. 2005 Jun 17;5:6.Franceschini D, Dinulos JG. Dermal melanocytosis and associated disorders. Curr Opin Pediatr. 2015 Aug;27(4):480-5.Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, Harp J, Takeshita J, French LE, Lim HW, Thiers BH, Hruza GJ, Fox LP. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct;83(4):1118-1129.Gansa W, Menon K, Sazeides C, Stewart O, Bogunovic D. Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome. Res Sq [Preprint]. 2023 Dec 4:rs.3.rs-3647800.Gibbs MB, English JC 3rd, Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol. 2005 Jun;52(6):1009-19.Goulden V, Goodfield MJ. Treatment of childhood dermatophyte infections with oral terbinafine. Pediatr Dermatol. 1995 Mar;12(1):53-4.Gupta AK, Sibbald RG, Lynde CW, Hull PR, Prussick R, Shear NH, De Doncker P, Daniel CR 3rd, Elewski BE. Onychomycosis in children: prevalence and treatment strategies. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):395-402.Gupta D, Thappa DM. Mongolian spots. Indian J Dermatol Venereol Leprol. 2013a Jul-Aug;79(4):469-78.Gupta D, Thappa DM. Mongolian spots--a prospective study. Pediatr Dermatol. 2013b Nov-Dec;30(6):683-8.Gupta AK, Venkataraman M, Shear NH, Piguet V. Onychomycosis in children - review on treatment and management strategies. J Dermatolog Treat. 2022 May;33(3):1213-1224.Gupta AK, Polla Ravi S, Haas-Neill S, Wang T, Cooper EA. Utility of devices for onychomycosis: a review. J Dermatolog Treat. 2023 Dec;34(1):2265658.Hasse L, Jamiolkowski D, Reschke F, Kapitzke K, Weiskorn J, Kordonouri O, Biester T, Ott H. Pediatric obesity and skin disease: cutaneous findings and associated quality-of-life impairments in 103 children and adolescents with obesity. Endocr Connect. 2023 Aug 2;12(9):e230235.Herzog V, Kirfel G, Siemes C, Schmitz A. Biological roles of APP in the epidermis. Eur J Cell Biol. 2004 Dec;83(11-12):613-24.Jackson JM, Alexis A, Zirwas M, Taylor S. Unmet needs for patients with seborrheic dermatitis. J Am Acad Dermatol. 2022 Dec 17:S0190-9622(22)03307-2.von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol. 1998 Mar;91(3):319-23.Kanbara Y, Takeuchi C, Mochizuki Y, Osako M, Sasaki M, Miyake H. Medical Needs of Adults with Down Syndrome Presenting at a Regional Medical and Rehabilitation Center in Japan. J Nippon Med Sch. 2023 May 30;90(2):210-219.Kavanagh GM, Leeming JP, Marshman GM, Reynolds NJ, Burton JL. Folliculitis in Down's syndrome. Br J Dermatol. 1993 Dec;129(6):696-9.Kim JH, Uh JA, Kim HS, Lee SK, Kim MS, Lee UH. Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases. Clin Exp Vaccine Res. 2022 Sep;11(3):298-301.Kodali N, Patel VM, Schwartz RA. Keratosis pilaris: an update and approach to management. Ital J Dermatol Venerol. 2023 Jun;158(3):217-223.Lam M, Lu JD, Elhadad L, Sibbald C, Alhusayen RCommon Dermatologic Disorders in Down Syndrome: Systematic Review JMIR Dermatol 2022;5(1):e33391.Le Cleach L, Lebrun-Vignes B, Bachelot A, Beer F, Berger P, Brugère S, Chastaing M, Do-Pham G, Ferry T, Gand-Gavanou J, Guigues B, Join-Lambert O, Henry P, Khallouf R, Lavie E, Maruani A, Romain O, Sassolas B, Tran VT, Guillot B; French Acne Guidelines Working Group and Centre of Evidence of Dermatology. Guidelines for the management of acne: recommendations from a French multidisciplinary group. Br J Dermatol. 2017 Oct;177(4):908-913.Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B,Leung AAM, Wong AHC. Onychomycosis: An Updated Review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45.Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea pedis: an updated review. Drugs Context. 2023 Jun 29;12:2023-5-1.Lobefaro F, Gualdi G, Di Nuzzo S, Amerio P. Atopic Dermatitis: Clinical Aspects and Unmet Needs. Biomedicines. 2022 Nov 14;10(11):2927.Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol. 2004;5(5):301-10.Lugović-Mihić L, Pilipović K, Crnarić I, Šitum M, Duvančić T. Differential Diagnosis of Cheilitis - How to Classify Cheilitis? Acta Clin Croat. 2018 Jun;57(2):342-351.Maranhão FCA, Mendonça NM, Teixeira TC, Lages GADCS, de Melo JA, Porciuncula CGG, da Silva Filho EA, Silva DMW. Molecular Identification of Candida Species in the Oral Microbiota of Individuals with Down Syndrome: A Case-Control Study. Mycopathologia. 2020 Jun;185(3):537-543.Mohiddin G, Narayanaswamy AB, Masthan KM, Nagarajan A, Panda A, Behura SS. Oral Candidal and Streptococcal carriage in Down syndrome patients. J Nat Sci Biol Med. 2015 Jul-Dec;6(2):300-5.Muñoz-Pérez MA, Camacho F. Acanthosis nigricans: a new cutaneous sign in severe atopic dermatitis and Down syndrome. J Eur Acad Dermatol Venereol. 2001 Jul;15(4):325-7.Muthusamy K, El-Jabali A, Ongie LJ, Dhamija R, Babovic-Vuksanovic D. Neurofibromatosis 1 in the setting of dual diagnosis: Diagnostic and management conundrums. Am J Med Genet A. 2022 Mar;188(3):911-918..Parlak AH, Koybasi S, Yavuz T, Yesildal N, Anul H, Aydogan I, Cetinkaya R, Kavak A. Prevalence of oral lesions in 13- to 16-year-old students in Duzce, Turkey. Oral Dis. 2006 Nov;12(6):553-8.Patil S, Doni B, Maheshwari S. Prevalence and distribution of oral mucosal lesions in a geriatric Indian population. Can Geriatr J. 2015 Mar 31;18(1):11-4.Penna HM, Modolo NSP, Paiva DH. Livedo reticular por hipotermia durante anestesia para tratamento odontológico em paciente com síndrome de Down [Livedo reticularis by hypothermia during anesthesia for dental treatment in Down's syndrome patient]. Braz J Anesthesiol. 2019 Jan-Feb;69(1):78-81.Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014 Jul;5(3):239-49.PNDS: Trisomie 21, HAS 2020. Téléchargeable sur www.has-sante.frRitter AM, Wine Lee L. Keratosis pilaris in collagen type VI-related disorders. Pediatr Dermatol. 2022 Jan;39(1):133-134. doi: 10.1111/pde.14883. Epub 2022 Jan 5. PMID: 34986511.Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep;37(5):811-816.Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatr Dermatol. 2021 Nov;38 Suppl 2:49-57.Sajjan VV, Lunge S, Swamy MB, Pandit AM. Livedo reticularis: A review of the literature. Indian Dermatol Online J 2015;6:315-21.Satgé D, Sasco AJ, Goldgar D, Vekemans M, Réthoré MO. A 23-year-old woman with Down syndrome, type 1 neurofibromatosis, and breast carcinoma. Am J Med Genet A. 2004 Feb 15;125A(1):94-6.Sechi A, Guglielmo A, Patrizi A, Savoia F, Cocchi G, Leuzzi M, Chessa MA. Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls. Dermatol Pract Concept. 2019 Jul 31;9(3):187-194.Schaffer R, Goss L, Romer MM, Kalamchi S. Down syndrome and neurofibromatosis: a case report. Spec Care Dentist. 2014 Nov-Dec;34(6):313-8.Schepis C, Siragusa M. Secondary anetoderma in people with Down's syndrome. Acta Derm Venereol. 1999 May;79(3):245.Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205(3):234-8.Scully C, van Bruggen W, Diz Dios P, Casal B, Porter S, Davison MF. Down syndrome: lip lesions (angular stomatitis and fissures) and Candida albicans. Br J Dermatol. 2002 Jul;147(1):37-40.Shukla D, Bablani D, Chowdhry A, Thapar R, Gupta P, Mishra S. Dentofacial and cranial changes in down syndrome. Osong Public Health Res Perspect. 2014 Dec;5(6):339-44.Simonart T. Down syndrome and delayed occurrence of acne. Dermatology. 2010;220(4):321-2.Sigurgeirsson B, Baran R. The prevalence of onychomycosis in the global population: a literature study. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1480-91.Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Dent Assoc. 2004 Sep;135(9):1279-86.Shulman JD. Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent. 2005 Mar;15(2):89-97.Sureshbabu R, Kumari R, Ranugha S, Sathyamoorthy R, Udayashankar C, Oudeacoumar P. Phenotypic and dermatological manifestations in Down Syndrome. Dermatol Online J. 2011 Feb 15;17(2):3.Totri CR, Feldstein S, Admani S, Friedlander SF, Eichenfield LF. Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population. Pediatr Dermatol. 2017 Jan;34(1):46-49.van Leeuwen RL, Berretty PJ, Knots E, Tan-Go I. Triad of juvenile xanthogranuloma, von Recklinghausen's neurofibromatosis and trisomy 21 in a young girl. Clin Exp Dermatol. 1996 May;21(3):248-9.Velthuis PJ, Nijenhuis M. Treatment of onychomycosis with terbinafine in patients with Down's syndrome.Br J Dermatol. 1995 Jul;133(1):144-6.Verstegen RHJ, Chang KJJ, Kusters MAA. Clinical implications of immune-mediated diseases in children with Down syndrome. Pediatr Allergy Immunol. 2020 Feb;31(2):117-123.Wentworth AB, Hand JL, Davis DM, Tollefson MM. Skin concerns in patients with trisomy 21 (Down syndrome): A Mayo Clinic 22-year retrospective review. Pediatr Dermatol. 2021 Nov;38 Suppl 2:73-78.Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945–73.e33.Zander N, Sommer R, Schäfer I, Reinert R, Kirsten N, Zyriax BC, Maul JT, Augustin M. Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees. Br J Dermatol. 2019 Oct;181(4):743-748.Zhong CS, Huang JT, Nambudiri VE. Revisiting the history of the "Mongolian spot": The background and implications of a medical term used today. Pediatr Dermatol. 2019 Sep;36(5):755-757....

PATHOLOGIES DERMATOLOGIQUES  Dermatologie courante et trisomie 21 - partie 2 PLAN DU CHAPITRE 1- Dermatologie et trisomie 21 – introduction 2- Dermatologie courante et trisomie 21 – partie 1 3- Dermatologie courante et trisomie 21 – partie 2 4- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 1 5- Pathologies dermatologiques souvent associées à la trisomie 21 – partie 2 6- Pathologies dermatologiques de survenue anecdotique dans la trisomie 21 (bientôt disponible) Le docteur Hervé Walti, pédiatre à l’Institut Jérôme Lejeune, nous parle, dans cette vidéo et dans la fiche technique qui l’accompagne, de la dermatologie dans la trisomie 21. Découvrez l’intégralité du chapitre « Pathologies dermatologiques » en cliquant sur "Plan du chapitre" à droite de l'image en haut de l'article. https://youtu.be/pYpRtL9Go58 Télécharger la fiche récapitulative Découvrez ci-dessous la présentation associée à cette vidéo. Voir les références Ali SY, Manne V, Manne R, Himani C. Neurofibromatosis, Down's syndrome, and acquired abnormalities. Indian Dermatol Online J. 2016 May-Jun;7(3):198-200.Alter SJ, McDonald MB, Schloemer J, Simon R, Trevino J. Common Child and Adolescent Cutaneous Infestations and Fungal Infections. Curr Probl Pediatr Adolesc Health Care. 2018 Jan;48(1):3-25.Al-Maweri SA, Tarakji B, Al-Sufyani GA, Al-Shamiri HM, Gazal G. Lip and oral lesions in children with Down syndrome. A controlled study. J Clin Exp Dent. 2015 Apr 1;7(2):e284-8.Anderson S. Café au Lait Macules and Associated Genetic Syndromes. J Pediatr Health Care. 2020 Jan-Feb;34(1):71-81.Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P. Positionspapier: Diagnostik und Therapie der Xerosis cutis. J Dtsch Dermatol Ges. 2018 Jul;16 Suppl 4:3-35.Axéll T, Skoglund A. Chronic lip fissures. Prevalence, pathology and treatment. Int J Oral Surg. 1981 Oct;10(5):354-8.Axéll T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy 1976;27:1-103.Bagatin E, Kamamoto CS, Guadanhim LR, Sanudo A, Dias MC, Barraviera IM, Colombo FC. Prevalence of acne vulgaris in patients with Down syndrome. Dermatology. 2010;220(4):333-9.Bagatin E, Timpano DL, Guadanhim LR, Nogueira VM, Terzian LR, Steiner D, Florez M. Acne vulgaris: prevalence and clinical forms in adolescents from São Paulo, Brazil. An Bras Dermatol. 2014 May-Jun;89(3):428-35.Bilgili SG, Akdeniz N, Karadag AS, Akbayram S, Calka O, Ozkol HU. Mucocutaneous disorders in children with down syndrome: case-controlled study. Genet Couns. 2011;22(4):385-92.Blagec T, Glavina A, Špiljak B, Bešlić I, Bulat V, Lugović-Mihić L. Cheilitis: A cross-sectional study-multiple factors involved in the aetiology and clinical features. Oral Dis. 2023 Nov;29(8):3360-3371.Blok J, Jonkman M, Horváth B. The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link? Br J Dermatol. 2014 Jun;170(6):1375-7. doi: 10.1111/bjd.12887.Bonifaz A, Saúl A, Mena C, Valencia A, Paredes V, Fierro L, Araiza J. Dermatophyte onychomycosis in children under 2 years of age: experience of 16 cases. J Eur Acad Dermatol Venereol. 2007 Jan;21(1):115-7.Butterworth T, Leoni EP, Beerman H, Wood MG, Strean LP. Cheilitis of mongolism. J Invest Dermatol. 1960 Dec;35:347-52.Camacho, F.M.; Mazuecos, J.; Ferrándiz, L. Cantalejo, C.; Cabello, Á. Phenotypical and dermatological findings of Down syndrome in Southern Spain. Eur. J. Pediat. Derm. 2014, 24, 7–12.Carlstedt K, Krekmanova L, Dahllöf G, Ericsson B, Braathen G, Modéer T. Oral carriage of Candida species in children and adolescents with Down's syndrome. Int J Paediatr Dent. 1996 Jun;6(2):95-100.Carvalho AA, Ferraz LDA, Martelli DRB, Machado RA, Martelli Júnior H. Craniofacial findings in syndromes associated with cafe-au-lait spots: a literature review. Rev Assoc Med Bras (1992). 2023 Jan 9;69(1):195-202.Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397-9.Cardoso Fernandes LC, de Araújo Oliveira J, Rabello PM, Santiago BM, Diniz de Carvalho MV, Soriano EP. Cheiloscopy in individuals with Down syndrome and their nonsyndromic biological siblings. J Forensic Odontostomatol. 2019 Sep 30;37(2):9-17.Coattrenec Y, Terrani I, Spoer D. La Rev Med Suisse 2018 ; 14 : 746-50.Contaldo M., Santoro R., Romano A., Loffredo F., Di Stasio D., Della Vella F., Scivetti M., Petruzzi M., Serpico R., Lucchese A. Oral Manifestations in Children and Young Adults with Down Syndrome: A Systematic Review of the Literature. Appl. Sci. 2021;11:5408.Cozzani E, Agnoletti AF, Speziari S, Schiavetti I, Zotti M, Persi A, Drago F, Parodi A. Epidemiological study of onychomycosis in older adults with onychodystrophy. Geriatr Gerontol Int. 2016 Apr;16(4):486-91.Dall'Oglio F, Nasca MR, Gerbino C, Micali G. An Overview of the Diagnosis and Management of Seborrheic Dermatitis. Clin Cosmet Investig Dermatol. 2022 Aug 6;15:1537-1548.Daneshpazhooh M, Nazemi TM, Bigdeloo L, Yoosefi M. Mucocutaneous findings in 100 children with Down syndrome. Pediatr Dermatol. 2007 May-Jun;24(3):317-20.Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T, Jafferany M, Grabbe S, Goldust M. Acanthosis nigricans: A review. J Cosmet Dermatol. 2020 Aug;19(8):1857-1865.Real de Asua D, Quero M, Moldenhauer F, Suarez C. Clinical profile and main comorbidities of Spanish adults with Down syndrome. Eur J Intern Med. 2015 Jul;26(6):385-91.de Lusignan S, Alexander H, Broderick C, Dennis J, McGovern A, Feeney C, Flohr C. The epidemiology of eczema in children and adults in England: A population-based study using primary care data. Clin Exp Allergy. 2021 Mar;51(3):471-482. doi: 10.1111/cea.13784. Epub 2020 Nov 26. PMID: 33179341; PMCID: PMC7984097.Drivenes JL, Vasilescu IC, Bygum A. Keratosis pilaris. Tidsskr Nor Laegeforen. 2023 Mar 7;143(5). English, Norwegian.Egemen A, Ikizoğlu T, Ergör S, Mete Asar G, Yilmaz O. Frequency and characteristics of mongolian spots among Turkish children in Aegean region. Turk J Pediatr. 2006 Jul-Sep;48(3):232-6.Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996 Nov;50(5):317-20.Finn OA, Grant PW, McCallum DI, Raffle EJ. A singular dermatosis of Mongols. Arch Dermatol. 1978 Oct;114(10):1493-4.Firsowicz M, Boyd M, Jacks SK. Follicular occlusion disorders in Down syndrome patients. Pediatr Dermatol. 2020 Jan;37(1):219-221.Fitzpatrick V, Rivelli A, Chaudhari S, Chicoine L, Jia G, Rzhetsky A, Chicoine B. Prevalence of infectious diseases among 6078 individuals with Down syndrome in the United States.J Patient Cent Res Rev. 2022;9:64-9.Fonseca CT, Amaral DM, Ribeiro MG, Beserra IC, Guimarães MM. Insulin resistance in adolescents with Down syndrome: a cross-sectional study. BMC Endocr Disord. 2005 Jun 17;5:6.Franceschini D, Dinulos JG. Dermal melanocytosis and associated disorders. Curr Opin Pediatr. 2015 Aug;27(4):480-5.Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR, Harp J, Takeshita J, French LE, Lim HW, Thiers BH, Hruza GJ, Fox LP. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct;83(4):1118-1129.Gansa W, Menon K, Sazeides C, Stewart O, Bogunovic D. Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome. Res Sq [Preprint]. 2023 Dec 4:rs.3.rs-3647800.Gibbs MB, English JC 3rd, Zirwas MJ. Livedo reticularis: an update. J Am Acad Dermatol. 2005 Jun;52(6):1009-19.Goulden V, Goodfield MJ. Treatment of childhood dermatophyte infections with oral terbinafine. Pediatr Dermatol. 1995 Mar;12(1):53-4.Gupta AK, Sibbald RG, Lynde CW, Hull PR, Prussick R, Shear NH, De Doncker P, Daniel CR 3rd, Elewski BE. Onychomycosis in children: prevalence and treatment strategies. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):395-402.Gupta D, Thappa DM. Mongolian spots. Indian J Dermatol Venereol Leprol. 2013a Jul-Aug;79(4):469-78.Gupta D, Thappa DM. Mongolian spots--a prospective study. Pediatr Dermatol. 2013b Nov-Dec;30(6):683-8.Gupta AK, Venkataraman M, Shear NH, Piguet V. Onychomycosis in children - review on treatment and management strategies. J Dermatolog Treat. 2022 May;33(3):1213-1224.Gupta AK, Polla Ravi S, Haas-Neill S, Wang T, Cooper EA. Utility of devices for onychomycosis: a review. J Dermatolog Treat. 2023 Dec;34(1):2265658.Hasse L, Jamiolkowski D, Reschke F, Kapitzke K, Weiskorn J, Kordonouri O, Biester T, Ott H. Pediatric obesity and skin disease: cutaneous findings and associated quality-of-life impairments in 103 children and adolescents with obesity. Endocr Connect. 2023 Aug 2;12(9):e230235.Herzog V, Kirfel G, Siemes C, Schmitz A. Biological roles of APP in the epidermis. Eur J Cell Biol. 2004 Dec;83(11-12):613-24.Jackson JM, Alexis A, Zirwas M, Taylor S. Unmet needs for patients with seborrheic dermatitis. J Am Acad Dermatol. 2022 Dec 17:S0190-9622(22)03307-2.von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol. 1998 Mar;91(3):319-23.Kanbara Y, Takeuchi C, Mochizuki Y, Osako M, Sasaki M, Miyake H. Medical Needs of Adults with Down Syndrome Presenting at a Regional Medical and Rehabilitation Center in Japan. J Nippon Med Sch. 2023 May 30;90(2):210-219.Kavanagh GM, Leeming JP, Marshman GM, Reynolds NJ, Burton JL. Folliculitis in Down's syndrome. Br J Dermatol. 1993 Dec;129(6):696-9.Kim JH, Uh JA, Kim HS, Lee SK, Kim MS, Lee UH. Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases. Clin Exp Vaccine Res. 2022 Sep;11(3):298-301.Kodali N, Patel VM, Schwartz RA. Keratosis pilaris: an update and approach to management. Ital J Dermatol Venerol. 2023 Jun;158(3):217-223.Lam M, Lu JD, Elhadad L, Sibbald C, Alhusayen RCommon Dermatologic Disorders in Down Syndrome: Systematic Review JMIR Dermatol 2022;5(1):e33391.Le Cleach L, Lebrun-Vignes B, Bachelot A, Beer F, Berger P, Brugère S, Chastaing M, Do-Pham G, Ferry T, Gand-Gavanou J, Guigues B, Join-Lambert O, Henry P, Khallouf R, Lavie E, Maruani A, Romain O, Sassolas B, Tran VT, Guillot B; French Acne Guidelines Working Group and Centre of Evidence of Dermatology. Guidelines for the management of acne: recommendations from a French multidisciplinary group. Br J Dermatol. 2017 Oct;177(4):908-913.Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B,Leung AAM, Wong AHC. Onychomycosis: An Updated Review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45.Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Tinea pedis: an updated review. Drugs Context. 2023 Jun 29;12:2023-5-1.Lobefaro F, Gualdi G, Di Nuzzo S, Amerio P. Atopic Dermatitis: Clinical Aspects and Unmet Needs. Biomedicines. 2022 Nov 14;10(11):2927.Luelmo-Aguilar J, Santandreu MS. Folliculitis: recognition and management. Am J Clin Dermatol. 2004;5(5):301-10.Lugović-Mihić L, Pilipović K, Crnarić I, Šitum M, Duvančić T. Differential Diagnosis of Cheilitis - How to Classify Cheilitis? Acta Clin Croat. 2018 Jun;57(2):342-351.Maranhão FCA, Mendonça NM, Teixeira TC, Lages GADCS, de Melo JA, Porciuncula CGG, da Silva Filho EA, Silva DMW. Molecular Identification of Candida Species in the Oral Microbiota of Individuals with Down Syndrome: A Case-Control Study. Mycopathologia. 2020 Jun;185(3):537-543.Mohiddin G, Narayanaswamy AB, Masthan KM, Nagarajan A, Panda A, Behura SS. Oral Candidal and Streptococcal carriage in Down syndrome patients. J Nat Sci Biol Med. 2015 Jul-Dec;6(2):300-5.Muñoz-Pérez MA, Camacho F. Acanthosis nigricans: a new cutaneous sign in severe atopic dermatitis and Down syndrome. J Eur Acad Dermatol Venereol. 2001 Jul;15(4):325-7.Muthusamy K, El-Jabali A, Ongie LJ, Dhamija R, Babovic-Vuksanovic D. Neurofibromatosis 1 in the setting of dual diagnosis: Diagnostic and management conundrums. Am J Med Genet A. 2022 Mar;188(3):911-918..Parlak AH, Koybasi S, Yavuz T, Yesildal N, Anul H, Aydogan I, Cetinkaya R, Kavak A. Prevalence of oral lesions in 13- to 16-year-old students in Duzce, Turkey. Oral Dis. 2006 Nov;12(6):553-8.Patil S, Doni B, Maheshwari S. Prevalence and distribution of oral mucosal lesions in a geriatric Indian population. Can Geriatr J. 2015 Mar 31;18(1):11-4.Penna HM, Modolo NSP, Paiva DH. Livedo reticular por hipotermia durante anestesia para tratamento odontológico em paciente com síndrome de Down [Livedo reticularis by hypothermia during anesthesia for dental treatment in Down's syndrome patient]. Braz J Anesthesiol. 2019 Jan-Feb;69(1):78-81.Phiske MM. An approach to acanthosis nigricans. Indian Dermatol Online J. 2014 Jul;5(3):239-49.PNDS: Trisomie 21, HAS 2020. Téléchargeable sur www.has-sante.frRitter AM, Wine Lee L. Keratosis pilaris in collagen type VI-related disorders. Pediatr Dermatol. 2022 Jan;39(1):133-134. doi: 10.1111/pde.14883. Epub 2022 Jan 5. PMID: 34986511.Rork JF, McCormack L, Lal K, Wiss K, Belazarian L. Dermatologic conditions in Down syndrome: A single-center retrospective chart review. Pediatr Dermatol. 2020 Sep;37(5):811-816.Ryan C, Vellody K, Belazarian L, Rork JF. Dermatologic conditions in Down syndrome. Pediatr Dermatol. 2021 Nov;38 Suppl 2:49-57.Sajjan VV, Lunge S, Swamy MB, Pandit AM. Livedo reticularis: A review of the literature. Indian Dermatol Online J 2015;6:315-21.Satgé D, Sasco AJ, Goldgar D, Vekemans M, Réthoré MO. A 23-year-old woman with Down syndrome, type 1 neurofibromatosis, and breast carcinoma. Am J Med Genet A. 2004 Feb 15;125A(1):94-6.Sechi A, Guglielmo A, Patrizi A, Savoia F, Cocchi G, Leuzzi M, Chessa MA. Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls. Dermatol Pract Concept. 2019 Jul 31;9(3):187-194.Schaffer R, Goss L, Romer MM, Kalamchi S. Down syndrome and neurofibromatosis: a case report. Spec Care Dentist. 2014 Nov-Dec;34(6):313-8.Schepis C, Siragusa M. Secondary anetoderma in people with Down's syndrome. Acta Derm Venereol. 1999 May;79(3):245.Schepis C, Barone C, Siragusa M, Pettinato R, Romano C. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;205(3):234-8.Scully C, van Bruggen W, Diz Dios P, Casal B, Porter S, Davison MF. Down syndrome: lip lesions (angular stomatitis and fissures) and Candida albicans. Br J Dermatol. 2002 Jul;147(1):37-40.Shukla D, Bablani D, Chowdhry A, Thapar R, Gupta P, Mishra S. Dentofacial and cranial changes in down syndrome. Osong Public Health Res Perspect. 2014 Dec;5(6):339-44.Simonart T. Down syndrome and delayed occurrence of acne. Dermatology. 2010;220(4):321-2.Sigurgeirsson B, Baran R. The prevalence of onychomycosis in the global population: a literature study. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1480-91.Shulman JD, Beach MM, Rivera-Hidalgo F. The prevalence of oral mucosal lesions in U.S. adults: data from the Third National Health and Nutrition Examination Survey, 1988-1994. J Am Dent Assoc. 2004 Sep;135(9):1279-86.Shulman JD. Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent. 2005 Mar;15(2):89-97.Sureshbabu R, Kumari R, Ranugha S, Sathyamoorthy R, Udayashankar C, Oudeacoumar P. Phenotypic and dermatological manifestations in Down Syndrome. Dermatol Online J. 2011 Feb 15;17(2):3.Totri CR, Feldstein S, Admani S, Friedlander SF, Eichenfield LF. Epidemiologic Analysis of Onychomycosis in the San Diego Pediatric Population. Pediatr Dermatol. 2017 Jan;34(1):46-49.van Leeuwen RL, Berretty PJ, Knots E, Tan-Go I. Triad of juvenile xanthogranuloma, von Recklinghausen's neurofibromatosis and trisomy 21 in a young girl. Clin Exp Dermatol. 1996 May;21(3):248-9.Velthuis PJ, Nijenhuis M. Treatment of onychomycosis with terbinafine in patients with Down's syndrome.Br J Dermatol. 1995 Jul;133(1):144-6.Verstegen RHJ, Chang KJJ, Kusters MAA. Clinical implications of immune-mediated diseases in children with Down syndrome. Pediatr Allergy Immunol. 2020 Feb;31(2):117-123.Wentworth AB, Hand JL, Davis DM, Tollefson MM. Skin concerns in patients with trisomy 21 (Down syndrome): A Mayo Clinic 22-year retrospective review. Pediatr Dermatol. 2021 Nov;38 Suppl 2:73-78.Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945–73.e33.Zander N, Sommer R, Schäfer I, Reinert R, Kirsten N, Zyriax BC, Maul JT, Augustin M. Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees. Br J Dermatol. 2019 Oct;181(4):743-748.Zhong CS, Huang JT, Nambudiri VE. Revisiting the history of the "Mongolian spot": The background and implications of a medical term used today. Pediatr Dermatol. 2019 Sep;36(5):755-757....